ClinicalTrials.govpublic full text
PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment
prostate cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 435751
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.